
Full text loading...
Category: Clinical Microbiology
Chronic Hepatitis B, C, and D, Page 1 of 2
< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555819040/9781555819033_Chap03-1.gif /docserver/preview/fulltext/10.1128/9781555819040/9781555819033_Chap03-2.gifAbstract:
Viral hepatitis contributes significantly to the morbidity and mortality of at-risk individuals, particularly in chronic, untreated infections. Clinical symptoms vary from none (asymptomatic carriers) to fulminant liver failure. Hepatitis viruses A, B, C, D, and E are responsible for the majority of liver disease, with hepatitis A and E viruses being the least common of the culprits.
Diagnostic Microbiology of the Immunocompromised Host, Second Edition
. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.DMIH2-0025-2015Full text loading...
Diagnostic Microbiology of the Immunocompromised Host, Second Edition
. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.DMIH2-0025-2015Key HBV virion components.
Key HBV virion components.
Diagnostic Microbiology of the Immunocompromised Host, Second Edition
. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.DMIH2-0025-2015Phases and associated markers of CHB ( 23 , 25 , 187 , 188 ).
Diagnostic Microbiology of the Immunocompromised Host, Second Edition
. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.DMIH2-0025-2015HBV exacerbation/reactivation risk associated with pharmacologic immunosuppression ( 37 , 44 , 52 , 189 – 208 ).
HBV exacerbation/reactivation risk associated with pharmacologic immunosuppression ( 37 , 44 , 52 , 189 – 208 ).
Diagnostic Microbiology of the Immunocompromised Host, Second Edition
. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.DMIH2-0025-2015CDC testing algorithm for the identification of patients with CHC. Adapted from reference ( 13 ).
CDC testing algorithm for the identification of patients with CHC. Adapted from reference ( 13 ).
Diagnostic Microbiology of the Immunocompromised Host, Second Edition
. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.DMIH2-0025-2015SVR rates with various regimens over the last 30 years ( 112 , 113 , 116 , 123 , 166 – 168 , 170 , 172 , 209 – 220 ).
SVR rates with various regimens over the last 30 years ( 112 , 113 , 116 , 123 , 166 – 168 , 170 , 172 , 209 – 220 ).
Diagnostic Microbiology of the Immunocompromised Host, Second Edition
. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.DMIH2-0025-2015Regimens currently recommended for treatment of CHC ( 7 ).
Regimens currently recommended for treatment of CHC ( 7 ).
Diagnostic Microbiology of the Immunocompromised Host, Second Edition
. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.DMIH2-0025-2015Current recommendations for viral load monitoring during treatment for CHC ( 7 ).
Current recommendations for viral load monitoring during treatment for CHC ( 7 ).
Diagnostic Microbiology of the Immunocompromised Host, Second Edition
. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.DMIH2-0025-2015